Trial Profile
Systems Biology of Trivalent Influenza Vaccine (TIV) in Young and Elderly.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 01 Mar 2012 Actual end date (October 2011) added as reported by ClinicalTrials.gov.
- 01 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.